A detailed history of Zweig Di Menna Associates LLC transactions in Glaukos Corp stock. As of the latest transaction made, Zweig Di Menna Associates LLC holds 58,665 shares of GKOS stock, worth $9.4 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
58,665
Holding current value
$9.4 Million
% of portfolio
0.7%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

BUY
$126.42 - $152.67 $7.42 Million - $8.96 Million
58,665 New
58,665 $8.8 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.63B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Zweig Di Menna Associates LLC Portfolio

Follow Zweig Di Menna Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zweig Di Menna Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zweig Di Menna Associates LLC with notifications on news.